Reading the tape
NYSE: MCK
McKesson Corporation
Healthcare · Medical - Distribution
Market Cap
$98.95B
52w High
$999.00
52w Low
$637.00
P/E
22.93
Volume
573.99K
Outstanding Shares
122.49M
Price vs Fundamentals
Why The Stock Is Moving
Fundamentals are supporting the moveModerate confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 14.26%Revenue (TTM): 15.49%FCF (TTM): 517.87%P/FCF: 49th pct
What changed
The stock rose 14.26% over the last year. Revenue grew 15.49% over the trailing twelve months. Operating margin moved from 1.3% to 1.3%. Free cash flow grew 517.87% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum, and the shares are still only around the 49th percentile of their historical P/FCF range.
What would invalidate this read
Operating margin is at 1.3%. Revenue grew 15.49% — this thesis depends on that trajectory holding. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Company profile
McKesson Corporation provides healthcare services in the United States and internationally.
CEOBrian S. Tyler
SectorHealthcare
IndustryMedical - Distribution
Employees44,000
IPO dateNov 10, 1994
Valuation
Forward P/E—
EV/EBITDA16.65
Enterprise value$87.44B
Stock splits
Jan 5, 1998↑ Forward
Every 1 shares became 2
Profitability & growth
Revenue growth11.4%
Gross margin3.37%▼11.96%vs FY2024
Operating margin1.3%▼4.20%vs FY2024
ROE-158.87%▼4.31%vs FY2024
Analyst consensus
RatingBuy
Target price$1,006.50▲24.59%
25
Buy
6
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
Q2 FY26 · EPS est $11.56 · Revenue est $101.35B
View
Dividends
$3.28/shareQuarterlyDividend Aristocrat · 26yrEx-div Jun 1, 2026 · in 27dSafeMCK pays a dividend with a 0.41% declared yield, 26 consecutive years of growth, growing at 14.32% annually, covered 15.1× by free cash flow.
Declared Yield
0.41%
Annual Div / Share
$3.28
TTM $3.17
5yr CAGR
+14.32%
Doubles every ~5.2yr
Payout Ratio
8.55%
Safe
Dividend Growth Rate
3yr CAGR
+14.94%
5yr CAGR
+14.32%
10yr CAGR
+11.34%
Dividend Safety
10/10Safe
Dividend History
Annualized dividend cycles per share
YearAnnual DivYoY
2026$3.28+15.5%
2025$2.84+14.5%
2024$2.48+14.8%
2023$2.16+14.9%
2022$1.88+11.9%
2021$1.68+2.4%
2020$1.64+5.1%
Income Projection
Invest
$
Growth rate:
Reinvest dividends
Today
$4/yr
$0/mo
In 5 yrs
$7/yr+76%
$1/mo
In 10 yrs
$13/yr+211%
$1/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$4/yr $0/mo | $7/yr+76% $1/mo | $13/yr+211% $1/mo |
Long-range projections use a capped 12% annual growth assumption.
Yield-on-cost grows from 0.41% → 1.26% over 10yr
Analysis
Dividend Strengths
Dividend Aristocrat
MCK has raised its dividend for 26 consecutive years — qualifying as a Dividend Aristocrat, demonstrating long-term commitment to shareholder income.
Well-covered by free cash flow
The dividend is covered 15.1× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Strong dividend growth rate
The 5-year CAGR of 14.32% meaningfully outpaces inflation, compounding real income growth for long-term holders.
Risks to Watch
No strong risk signal stands out from the latest period pair.
Congressional Activity
Congress Trades in MCK
STOCK Act disclosures from senators and representatives.
Lizzie Fletcher
TXhouseDemocratSale2026-04-08$1,001 - $15,000+23d to disclose
Markwayne Mullin
OKsenateRepublicanPurchaseJoint2026-02-04$15,001 - $50,000+26d to discloseMarkwayne Mullin
OKsenateRepublicanPurchaseSpouse2026-01-05$15,001 - $50,000+29d to discloseMarkwayne Mullin
OKsenateRepublicanPurchaseSelf2026-01-05$15,001 - $50,000+29d to disclose